Joachim Seipelt | CBO
Nuvonis Technologies GmbH

Joachim Seipelt is an experienced biotech manager with a strong background in virology and vaccine development. He has experience in research (Boehringer Ingelheim, Medical University Vienna), company co-founding (AVIR Green Hills Biotechnology), managing large funding programs (Austria Wirtschaftsservice GmbH), and leading operations at a clinical-stage biotech company (BlueSky Immunotherapies). Currently, he heads Nuvonis Technologies and advises G.ST Antivirals.